Ep44: Utilizing Virtual Reality for Digital Therapeutics

In this episode, we hear from Sammeli Liikkanen, Digital Medicines Director at Orion Corporation. Orion Pharma is a globally operating Finnish pharmaceutical company with core therapy areas of neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases.

In this episode, we cover:

• How Orion approaches non-molecular innovation

• Solving misconceptions in digital medicine

• VR as a modality for DTx

• Patient experience using VR

• Approaches to evidence generation

• Commercializing stand alone DTx vs Drug+

Guest Links and Resources:

• Connect with Sammeli Liikkanen on LinkedIn

• Visit https://www.orion.fi/en/

Host Links:

• Connect with Eugene Borukhovich: Twitter | LinkedIn

• Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn

• Connect with YourCoach.health: Website | Twitter

• Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App

• HealthXL: Website | Twitter | Join an Event

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram